Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-28 @ 10:20 AM
Study NCT ID:
NCT03348904
Status:
TERMINATED
Last Update Posted:
2019-06-13
First Post:
2017-11-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-16
First Submit QC Date:
None
Study First Post Date:
2017-11-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-05-22
Results First Submit QC Date:
None
Results First Post Date:
2019-06-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-12
Last Update Post Date:
2019-06-13
Last Update Post Date Type:
ACTUAL